My Endometrial Cancer has spread to my bones — how is this treated

Endometrial Cancer with Bone Metastases: Treatment Overview

I'm sorry you're dealing with this diagnosis. Let me help you understand how doctors typically approach endometrial cancer that has spread to the bones, and what questions to ask your care team.

How Doctors Think About This Situation

When endometrial cancer spreads to bones (called bone metastases), your oncology team considers several factors:

• The extent of spread — how many bones are affected and whether there are other metastatic sites
• Your overall health and ability to tolerate treatment
• The type of endometrial cancer — whether it's endometrioid, serous, carcinosarcoma, or another subtype
• Prior treatments you've received
• Symptoms — whether you have bone pain, fracture risk, or spinal cord compression

General Treatment Approaches for Advanced Endometrial Cancer

According to NCCN Guidelines for Uterine Neoplasms, treatment for advanced endometrial cancer typically involves:

1. Systemic Chemotherapy

This is often the foundation of treatment for metastatic disease. Common regimens may include:

• Doxorubicin and cisplatin combinations
• Paclitaxel-based regimens
• Other chemotherapy agents depending on your cancer's characteristics

2. Radiation Therapy

• Palliative radiation to specific bone sites causing pain or at risk for fracture
• Whole-abdominal radiation in select cases (though this is less common now)
• Radiation can help relieve bone pain and prevent fractures

3. Bone-Strengthening Medications

These are important when cancer has spread to bones. According to NCCN Guidelines, medications that protect bone health include:

• Bisphosphonates (oral or IV forms like zoledronic acid/Zometa)
• Denosumab (Xgeva) — a newer option that works differently than bisphosphonates
• Pamidronate (Aredia)

These medications help by:

• Slowing or stopping bone breakdown
• Reducing fracture risk
• Relieving bone pain
• Lowering risk of spinal cord compression

4. Surgical Intervention

In select cases, surgery may be considered for:

• Stabilizing bones at high fracture risk
• Relieving spinal cord compression (an emergency situation)
• Removing isolated metastatic sites if feasible

5. Biomarker Testing

Your doctor may recommend testing your cancer for:

• MMR/MSI status (mismatch repair/microsatellite instability) — can indicate immunotherapy options
• TMB (tumor mutational burden)
• POLE mutations — associated with better prognosis
• PTEN, TP53, CTNNB1 mutations — may guide treatment selection

These tests help identify whether targeted therapies or immunotherapy might be appropriate for your specific cancer.

Important Supportive Care

• Calcium and Vitamin D supplementation — essential when on bone-protective medications
• Dental care — inform your dentist before starting bone-protective drugs, as they rarely can affect jaw bone health
• Monitoring — regular blood tests to check kidney function, calcium, and magnesium levels
• Pain management — addressing bone pain is a key part of treatment

Questions to Ask Your Oncology Team

Since YOUR specific situation requires your doctor's evaluation, here are targeted questions:

1. "What is the stage and extent of my metastatic disease? Are there sites beyond the bones?"

   • This determines whether treatment is curative intent or palliative

2. "What chemotherapy regimen do you recommend, and why this one for my cancer type?"

   • Different endometrial cancer subtypes respond differently to various drugs

3. "Will I receive bone-protective medication? Which one and for how long?"

   • Understand the specific drug, schedule, and monitoring required

4. "Do you recommend radiation to any specific bone sites, and what would that accomplish?"

   • Clarify whether this is for pain control, fracture prevention, or spinal cord compression risk

5. "Have you tested my cancer for MMR/MSI, TMB, or other biomarkers? What did those results show?"

   • These may open doors to additional treatment options like immunotherapy

6. "What is the treatment goal — to shrink the cancer, control symptoms, or both?"

   • Understanding realistic expectations helps with decision-making

7. "What side effects should I expect, and how will we manage them?"

   • Chemotherapy and bone medications have different side effect profiles

8. "How often will we scan to assess response, and what happens if the cancer progresses?"

   • Knowing the monitoring plan and backup options is important

Key Takeaway

Treatment of endometrial cancer with bone metastases typically combines chemotherapy as the primary systemic therapy with bone-protective medications, and sometimes radiation for specific painful or unstable sites. Your oncologist will determine the most appropriate approach based on your complete clinical picture, cancer characteristics, and overall health.

---

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.